Home › Funds › DUPONT CAPITAL MANAGEMENT CORP › OCS

DUPONT CAPITAL MANAGEMENT CORP position in OCS

OCULIS HOLDING AG · Health Care

DUPONT CAPITAL MANAGEMENT CORP reported holding 4 shares of OCS (OCULIS HOLDING AG) in its Q3 2026 13F filing — a position valued at US$37K, representing 0.00% of its reported portfolio and ranking #33 among its reported holdings. DUPONT CAPITAL MANAGEMENT CORP has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4 sh
Reported value held$37.00K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DUPONT CAPITAL MANAGEMENT CORP's OCS position evolved

DUPONT CAPITAL MANAGEMENT CORP first disclosed a stake in OCS in Q3 2023 at 4 shares (US$0K). The position peaked in Q2 2026 at 4 shares, worth US$55K. Across 13 filings, DUPONT CAPITAL MANAGEMENT CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4 shares valued at US$37K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4 $45 New
Q4 2023 4 $44 Hold
Q1 2024 4 $48 Hold
Q2 2024 4 $48 Hold
Q3 2024 4 $49 Hold
Q4 2024 4 $68 Hold
Q1 2025 4 $76 Hold
Q2 2025 4 $78 Hold
Q3 2025 4 $71 Hold
Q4 2025 4 $80 Hold
Q1 2026 4 $106 Hold
Q2 2026 4 $55.00K Hold
Q3 2026 4 $37.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCS and 13F data

OCS (OCULIS HOLDING AG) is a Health Care company. 65 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCS

All OCS fund holders →

FAQ

How long has DUPONT CAPITAL MANAGEMENT CORP held OCS?

DUPONT CAPITAL MANAGEMENT CORP has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DUPONT CAPITAL MANAGEMENT CORP's current position in OCS?

As of Q3 2026, DUPONT CAPITAL MANAGEMENT CORP holds 4 shares of OCS (OCULIS HOLDING AG), valued at $37.00K, representing 0.00% of its reported portfolio and ranking #33.

Has DUPONT CAPITAL MANAGEMENT CORP been buying or selling OCS?

In the latest 13F filing (Q3 2026), DUPONT CAPITAL MANAGEMENT CORP held unchanged its position in OCS. The position peaked in Q2 2026 at 4 shares.

Which other funds hold OCS?

Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.